A Psychedelic and Cannabis Research Revolution On the Horizon?

A Psychedelic and Cannabis Research Revolution On the Horizon?

Author: Cannabis Radio April 22, 2026 Duration: 29:28

This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental health disorders.

The newly signed executive order to direct the FDA to fast-track these compounds through new "National Priority" vouchers.

Beyond psychedelics, the host discusses the impact of GLP-1 weight-loss drugs (like Ozempic) on the cannabis market, noting that dispensaries are seeing a shift in consumer preference toward lower-dose products to mitigate "the munchies."



Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

There’s a lot more to the cannabis industry than what grows in the field. Blunt Business, from Cannabis Radio, digs into the complex reality of building and running a company in this fast-moving space. We’re talking about the real work behind the scenes-supply chain logistics, regulatory hurdles, branding in a crowded market, and managing teams in a unique cultural environment. Each episode brings together voices who are actually doing the job, from executives steering multi-state operations to entrepreneurs who just opened their first dispensary. You’ll hear candid roundtable discussions where strategies are debated, and interviews that get into the specifics of leadership and finance without the hype. This isn’t about advocacy or culture; it’s a practical look at the mechanics of a profitable, high-stakes business. Tune in for a podcast that cuts through the smoke and offers tangible insights you can apply, whether you’re an investor, a manager, or building your own venture from the ground up.
Author: Language: English Episodes: 100

Blunt Business
Podcast Episodes
New Blaze Retail Point of Sale System [not-audio_url] [/not-audio_url]

Duration: 27:45
Blaze CEO Chris Violas discussed Blaze’s newly updated retail point-of-sale (POS) system, which was designed with efficiency and user-friendliness in mind. The system offers features that enable front-of-house employees…
FTC & FDA Take Action Against Misleading Delta-8 THC Packaging [not-audio_url] [/not-audio_url]

Duration: 39:04
Blunt Business welcomes Tucker Herndon, managing partner at Burr & Forman, who addressed the FTC and FDA's issuance of cease and desist letters to companies marketing Delta-8 THC products that mimic children's snacks. Th…
How Cannabis Brands Can Navigate Vape Supply Chain Disruptions [not-audio_url] [/not-audio_url]

Duration: 35:08
Pete Sahani, the newly appointed CEO of the Blinc Group, is at the forefront of several groundbreaking initiatives aimed at addressing challenges within the cannabis vaping industry. One of the key strategies introduced…
Cannabis Reclassification and Firearm Fallout [not-audio_url] [/not-audio_url]

Duration: 34:02
Craig Small, Attorney with Clark Hill returns for a discussion on the reclassification of cannabis and its far-reaching ramifications for the firearm industry. We explore the intricate legal conflicts between federal and…
Teapot Tactics: Brewing Success in Cannabis Beverages [not-audio_url] [/not-audio_url]

Duration: 41:22
Paul Weaver, Head of Cannabis at Boston Beer Company, takes us through the company's bold venture into the cannabis market with their THC-infused iced tea product, Teapot. Discover how Boston Beer Company's expertise in…
Navigating Cannabis Insurance with Jay Virdi [not-audio_url] [/not-audio_url]

Duration: 40:36
We welcome Jay Virdi, Chief Sales Officer for Specialty Practices at HUB International, to discuss the evolving landscape of the cannabis industry and the complex world of cannabis insurance. Jay discusses the intricacie…